Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,296
Total Claims
$1.5M
Drug Cost
784
Beneficiaries
$1,906
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-97%
Opioid rate vs peers
0.1% vs 2.6% avg
+79%
Cost per patient vs peers
$1,906 vs $1,068 avg
+14%
Brand preference vs peers
10.3% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
14
Opioid Claims
$103
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,870 claims · $1.2M
Generic: 16,285 claims · $289K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 197 | $180K |
| Apixaban | 170 | $119K |
| Semaglutide | 98 | $115K |
| Fluticasone/Umeclidin/Vilanter | 132 | $111K |
| Rivaroxaban | 135 | $96K |
| Teriparatide | 13 | $59K |
| Dulaglutide | 36 | $56K |
| Dapagliflozin Propanediol | 57 | $46K |
| Mirabegron | 106 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 49 | $31K |
| Insulin Detemir | 28 | $27K |
| Ipratropium/Albuterol Sulfate | 28 | $27K |
| Liraglutide | 14 | $24K |
| Insulin Lispro Protamin/Lispro | 18 | $21K |
| Budesonide/Formoterol Fumarate | 45 | $19K |
Prescribing Profile
Patient Profile
76
Avg Age
56%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data